87212-002-01 - Initial

Manufacturer
Excelsior Commercial Inc
Effective date
2026-10-15
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-10-15 01:02:08

Label at a glance#

ProductMURASAKI BEAUTY CAPSAICIN 0.1% PAIN RELIEF
Active ingredientCAPSAICIN
Label structure13 sections

Indications and uses

For the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, and bruises.

Dosage and administration

Adults and children 12 years of age and older: Apply to affected area. Massage gently over the affected area. Apply not more than 3 to 4 times daily. Wash hands thoroughly with soap and water after application. Read carton for all uses and directions. Children under 12 years of age: consult a doctor.

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Capsaicin 0.1%(w/w)

OTC - PURPOSE SECTION

Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, and bruises.

Warnings

WARNINGS SECTION

For external use only.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older: Apply to affected area. Massage gently over the affected area. Apply not more than 3 to 4 times daily. Wash hands thoroughly with soap and water after application. Read carton for all uses and directions. Children under 12 years of age: consult a doctor.

Other information

OTHER SAFETY INFORMATION

Store at 15°–30°C (59°–86°F). Keep container tightly closed.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aloe barbadensis leaf juice, aminomethyl propanol, arnica montana flower water, butylene glycol, butyrospermum parkii (shea) butter, tricaprin, caprylyl glycol, carbomer, cetearyl alcohol, matricaria chamomilla flowering top, chrysanthellum indicum flower oil, ethylhexylglycerin, glyceryl stearate, lecithin soybean, menthyl lactate, niacinamide, panthenol, PEG-100 stearate, acrylic acid/sodium acrylate copolymer, sodium citrate, alpha-tocopherol acetate, water.

Questions or comments?

OTC - QUESTIONS SECTION

Distributed by Excelsior Commercial Inc., Chicago, Illinois 60616, United States. Questions or comments? service@murasakibeauty.com.

Do not use

OTC - DO NOT USE SECTION

Do not use on wounds or damaged skin.

When using this product

OTC - WHEN USING SECTION

Avoid contact with eyes. Do not apply to wounds or damaged skin. Do not bandage tightly. Do not use with a heating pad. A temporary burning sensation may occur upon application.

Stop use and ask a doctor if

OTC - STOP USE SECTION

Condition worsens; symptoms persist for more than 7 days; or symptoms clear up and occur again within a few days.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MURASAKI BEAUTY CAPSAICIN 0.1% PAIN RELIEF CREAM package labelMURASAKI BEAUTY CAPSAICIN 0.1% PAIN RELIEF CREAM package labelMURASAKI BEAUTY CAPSAICIN 0.1% PAIN RELIEF CREAM — NET WT 4.23 OZ (120 g)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87212-00287212-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MURASAKI BEAUTY CAPSAICIN 0.1% PAIN RELIEFCAPSAICIN 0.1%Excelsior Commercial Inc5c0d88dd-7791-7a74-e063-6394a90a21a82026-10-15WarningsExact identifier
ndc (package): 87212-002-01
ndc (product): 87212-002
ndc11 (package): 87212000201
spl id: 5c0d88dd-7792-7a74-e063-6394a90a21a8
spl set id: 5c0d88dd-7791-7a74-e063-6394a90a21a8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.